{"entity":{"type":"insider","cik":"0001604541","url":"/insider/0001604541","json_url":"/insider/0001604541.json","name":"Went Gregory T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":10,"first":"2015-03-19","last":"2019-03-21","span_basis":"filed_date"},"name_variants":[{"name":"Went Gregory T","source":"filing","n_filings":10,"first_seen":"2015-03-19","last_seen":"2019-03-21"}],"transactions":[{"id":8597971,"accession":"0001209191-19-020763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-020763","line_url":"/filing/0001209191-19-020763#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6319.0,"shares_display":"6,319","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":50488.81,"total_display":"50,488.81","total_whole":"50,489","shares_owned_after":176291.0,"shares_owned_after_display":"176,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-21","scope":"insider"},{"id":6001488,"accession":"0001209191-18-057797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-057797","line_url":"/filing/0001209191-18-057797#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3850.0,"shares_display":"3,850","price_per_share":12.9757,"price_display":"12.98","price_state":"stated","total_value":49956.445,"total_display":"49,956.44","total_whole":"49,956","shares_owned_after":199242.0,"shares_owned_after_display":"199,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-08","scope":"insider"},{"id":6198889,"accession":"0001209191-18-021318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021318","line_url":"/filing/0001209191-18-021318#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4541.0,"shares_display":"4,541","price_per_share":25.75,"price_display":"25.75","price_state":"stated","total_value":116930.75,"total_display":"116,930.75","total_whole":"116,931","shares_owned_after":182610.0,"shares_owned_after_display":"182,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-22","scope":"insider"},{"id":5201677,"accession":"0001209191-17-022342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-022342","line_url":"/filing/0001209191-17-022342#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2807.0,"shares_display":"2,807","price_per_share":17.03,"price_display":"17.03","price_state":"stated","total_value":47803.21,"total_display":"47,803.21","total_whole":"47,803","shares_owned_after":166526.0,"shares_owned_after_display":"166,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-22","scope":"insider"},{"id":8490051,"accession":"0001209191-15-042990","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-042990","line_url":"/filing/0001209191-15-042990","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":390792.0,"shares_owned_after_display":"390,792","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-14","scope":"insider","n_lines":2},{"id":8490039,"accession":"0001209191-15-042990","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-042990","line_url":"/filing/0001209191-15-042990","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128.0,"shares_display":"128","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":2304.0,"total_display":"2,304.00","total_whole":"2,304","shares_owned_after":390992.0,"shares_owned_after_display":"390,992","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-13","filed_date":"2015-05-14","scope":"insider","n_lines":2},{"id":8490022,"accession":"0001209191-15-042990","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-042990","line_url":"/filing/0001209191-15-042990","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":18.001304347826085,"price_display":"18.00","price_state":"stated","total_value":41403.0,"total_display":"41,403.00","total_whole":"41,403","shares_owned_after":391092.0,"shares_owned_after_display":"391,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider","n_lines":2},{"id":8811971,"accession":"0001209191-15-036405","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-036405","line_url":"/filing/0001209191-15-036405","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":18.003636363636364,"price_display":"18.00","price_state":"stated","total_value":59412.0,"total_display":"59,412.00","total_whole":"59,412","shares_owned_after":392892.0,"shares_owned_after_display":"392,892","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-23","filed_date":"2015-04-27","scope":"insider","n_lines":2},{"id":8921343,"accession":"0001209191-15-035609","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-035609","line_url":"/filing/0001209191-15-035609","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2773.0,"shares_display":"2,773","price_per_share":18.003787666786874,"price_display":"18.00","price_state":"stated","total_value":49924.5032,"total_display":"49,924.50","total_whole":"49,925","shares_owned_after":395292.0,"shares_owned_after_display":"395,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-21","filed_date":"2015-04-22","scope":"insider","n_lines":2},{"id":8921338,"accession":"0001209191-15-035609","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-035609","line_url":"/filing/0001209191-15-035609","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7810.0,"shares_display":"7,810","price_per_share":18.0002,"price_display":"18.00","price_state":"stated","total_value":140581.562,"total_display":"140,581.56","total_whole":"140,582","shares_owned_after":397103.0,"shares_owned_after_display":"397,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-20","filed_date":"2015-04-22","scope":"insider","n_lines":2},{"id":8691996,"accession":"0001209191-15-034122","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-034122","line_url":"/filing/0001209191-15-034122","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":3240.0,"total_display":"3,240.00","total_whole":"3,240","shares_owned_after":402303.0,"shares_owned_after_display":"402,303","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-14","scope":"insider","n_lines":2},{"id":8691986,"accession":"0001209191-15-034122","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-15-034122","line_url":"/filing/0001209191-15-034122#line-7","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.875,"price_display":"1.88","price_state":"stated","total_value":18750.0,"total_display":"18,750.00","total_whole":"18,750","shares_owned_after":20008.0,"shares_owned_after_display":"20,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-14","scope":"insider"},{"id":8691981,"accession":"0001209191-15-034122","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-034122","line_url":"/filing/0001209191-15-034122","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4577.0,"shares_display":"4,577","price_per_share":18.263445816036704,"price_display":"18.26","price_state":"stated","total_value":83591.7915,"total_display":"83,591.79","total_whole":"83,592","shares_owned_after":402903.0,"shares_owned_after_display":"402,903","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-10","filed_date":"2015-04-14","scope":"insider","n_lines":4},{"id":8248287,"accession":"0001209191-15-028851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-028851","line_url":"/filing/0001209191-15-028851","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":405980.0,"shares_owned_after_display":"405,980","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider","n_lines":2},{"id":8126470,"accession":"0001209191-15-028041","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-15-028041","line_url":"/filing/0001209191-15-028041","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4468.0,"shares_display":"4,468","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":80424.0,"total_display":"80,424.00","total_whole":"80,424","shares_owned_after":10008.0,"shares_owned_after_display":"10,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-19","scope":"insider","n_lines":2},{"id":8126461,"accession":"0001209191-15-028041","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-028041","line_url":"/filing/0001209191-15-028041","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14020.0,"shares_display":"14,020","price_per_share":18.00325320970043,"price_display":"18.00","price_state":"stated","total_value":252405.61,"total_display":"252,405.61","total_whole":"252,406","shares_owned_after":408328.0,"shares_owned_after_display":"408,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-19","scope":"insider","n_lines":2},{"id":8126453,"accession":"0001209191-15-028041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-028041","line_url":"/filing/0001209191-15-028041","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001604541","owner_name":"Went Gregory T","owner_display_name":"Went Gregory T","owner_url":"/insider/0001604541","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":82800.0,"total_display":"82,800.00","total_whole":"82,800","shares_owned_after":417748.0,"shares_owned_after_display":"417,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":10,"first_seen":"2015-03-19","last_seen":"2019-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604541","retrieved_at":"2026-08-24T01:34:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}